Former ODE V Director Weintraub
This article was originally published in The Tan Sheet
Executive Summary
Michael Weintraub, MD, named to the Tufts University Center for the Study of Drug Development advisory board. Weintraub left FDA's Office of Drug Evaluation V on July 3, succeeded by former oncology division director Robert DeLap, MD/PhD ("The Tan Sheet" June 8, p. 1). The Tufts center is a non-profit research group that focuses on scientific, economic, legal and public policy issues regarding pharmaceutical and biopharmaceutical R&D and regulation worldwide...
You may also be interested in...
Supplement GMP Warning Letters Make Modest Debut In 2010
Finalization of a settlement between the Federal Trade Commission and Rexall Sundown regarding unsupported cellulite treatment claims for the firm's Cellasene dietary supplement hinges upon approval of two related class action settlements pending in California and Florida, according to FTC
In Brief
Combe sells most of its OTC brands
People In Brief
Perrigo promotes in pricing, planning